Bifidobacterium infantis MAK22B04I and Reduced Intestinal Inflammation
2 of 2 papers
- 2014-10-10
- Pediatric Research 77(1-2)
- M. Underwood
- J. German
- C. Lebrilla
- D. Mills
- Moderate evidence
- Highly Cited
- Rigorous Journal
displays anti-inflammatory activity in premature intestinal cells
- Effect
- Beneficial
- Effect size
- Moderate
- 2022-04-13
- RCT
- Science Translational Medicine 14(640)
- Michael J. Barratt
- Sharika Nuzhat
- Kazi Ahsan
- S. Frese
- Aleksandr A. Arzamasov
- S. Sarker
- M. M. Islam
- P. Palit
- Md. Ridwan Islam
- M. Hibberd
- Swetha Nakshatri
- Carrie A. Cowardin
- J. Guruge
- A. Byrne
- Siddarth Venkatesh
- Vinaik Sundaresan
- B. Henrick
- R. Duar
- Ryan D. Mitchell
- G. Casaburi
- Johann Prambs
- Robin L. Flannery
- M. Mahfuz
- D. Rodionov
- A. Osterman
- David Kyle
- T. Ahmed
- J. Gordon
- Low evidence
- Rigorous Journal
- Animal Study
- Clinical
EVC001 treatment promoted weight gain that was associated with reduced intestinal inflammation markers in infants with SAM.
- Effect
- Beneficial
- Effect size
- Moderate